We are live on ! Find out more

Small Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
AHG
76
Akso Health Group
AHG
$1.25B
$1.25B $1.46 3.31%
ARDX icon
77
Ardelyx
ARDX
$1.25B
$1.25B $5.06 0.6%
ORIC icon
78
Oric Pharmaceuticals
ORIC
$1.24B
$1.24B $12.02 0.66%
NVAX icon
79
Novavax
NVAX
$1.23B
$1.23B $7.49 0.4%
AVLN
80
Avalyn Pharma
AVLN
$1.22B
$1.22B $27.62 1.18%
OMDA
81
Omada Health Inc
OMDA
$1.22B
$1.22B $20.58 0.24%
MNKD icon
82
MannKind Corp
MNKD
$1.22B
$1.22B $3.95 4.36%
IRMD icon
83
iRadimed
IRMD
$1.22B
$1.22B $95.08 0.62%
JBIO
84
Jade Biosciences
JBIO
$1.21B
$1.21B $19.95 0.65%
INBX icon
85
Inhibrx
INBX
$1.21B
$1.21B $82.45 1.1%
FRNM
86
Freenome, Inc. Common stock
FRNM
$1.21B
$1.21B $11.38 1.25%
CERT icon
87
Certara
CERT
$1.21B
$1.21B $7.75 3.2%
IMTX icon
88
Immatics
IMTX
$1.18B
$1.18B $8.63 4.96%
TNDM icon
89
Tandem Diabetes Care
TNDM
$1.18B
$1.18B $17.17 0.29%
AVNS icon
90
Avanos Medical
AVNS
$1.17B
$1.17B – –
USPH icon
91
US Physical Therapy
USPH
$1.17B
$1.17B $76.64 2.76%
ETON icon
92
Eton Pharmaceutcials
ETON
$1.16B
$1.16B $42.31 0.66%
COLL icon
93
Collegium Pharmaceutical
COLL
$1.15B
$1.15B $35.52 0.91%
QDEL icon
94
QuidelOrtho
QDEL
$1.15B
$1.15B $16.83 4.86%
STAA icon
95
STAAR Surgical
STAA
$1.14B
$1.14B $22.95 1.84%
SDGR icon
96
Schrodinger
SDGR
$1.14B
$1.14B $15.28 2.07%
MGTX icon
97
MeiraGTx Holdings
MGTX
$1.14B
$1.14B $12.30 4.5%
WVE icon
98
Wave Life Sciences
WVE
$1.14B
$1.14B $5.92 1.89%
SVRA icon
99
Savara
SVRA
$1.11B
$1.11B $5.43 1.45%
DRTS icon
100
Alpha Tau Medical
DRTS
$1.1B
$1.1B $12.21 2.32%
2 3
4
5 6

Small Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 305 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $268B.

The largest by market cap are Surgery Partners (SGRY) at $1.98B, NovoCure (NVCR) at $1.97B and ADMA Biologics (ADMA) at $1.97B.

Among institutional investors, Aktis Oncology (AKTS) drew the most net new fund positions in Q1 2026: 69 funds opened new positions.

  • Combined market cap: $268B across 305 stocks.
  • Small Cap: market cap between $250M and $2B.
  • Largest constituent: Surgery Partners (SGRY), $1.98B market cap.
  • Most net new fund positions in Q1 2026: Aktis Oncology (AKTS), +69 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.